Subsequent RCTs narrowed their focus on more specific hormonal factors and demonstrated efficacy with improved frequency of sexual intercourse, arousal, orgasm, and satisfaction.
Are there other medications that can result in sexual enhancement for women?
Addyi, for example, can take up to 8 weeks for a full effect. There are several medications that you shouldn’t take with Viagra, including certain heart and blood pressure medications. You should avoid Viagra if you’re taking any of these commonly prescribed medications: Certain blood pressure medications, like amlodipine and lisinopril Certain blood pressure medications, like amlodipine and lisinopril Make sure you discuss all medications and supplements you’re taking with a healthcare professional before you take Viagra. If a woman accidentally took Viagra, there wouldn’t likely be any sildenafil oral jelly 100mg lasting harmful effects. If you’re having trouble in your sex life, you may wonder if a pill could help.
Pulmonary hypertension
Though Viagra isn’t FDA approved for women, it’s sometimes used off-label to enhance arousal. Other medications may be able to help, too, including Addyi, Vyleesi, and Osphena. Talk with a healthcare professional you trust if you’re facing challenges in your sex life. There likely won’t be a quick fix, but they can help you understand whether medication might be an option for you. Natural supplements, therapy, and different forms of exercise may help too. One trial involved premenopausal women with sexual arousal disorder but with normal sexual desire.
| Product | Dosage | Quantity + Bonus | Price | |
|---|---|---|---|---|
| Viagra Generic | 200mg | 120 + 8 Pills | 204.80€ 195.05€ | |
| Viagra Generic | 25mg | 30 + 4 Pills | 47.97€ 45.69€ | |
| Kamagra | 100mg | 12 Pills | 55.64€ 52.99€ | |
| Viagra Generic | 200mg | 90 + 6 Pills | 170.79€ 162.66€ | |
| Kamagra | 100mg | 180 + 6 Pills | 436.79€ 415.99€ | |
| Viagra Generic | 50mg | 30 + 4 Pills | 54.26€ 51.68€ | |
| Viagra Generic | 25mg | 120 + 6 Pills | 125.56€ 119.58€ | |
| Kamagra | 100mg | 84 + 6 Pills | 264.44€ 251.85€ | |
| Viagra Generic | 50mg | 60 + 4 Pills | 83.93€ 79.93€ | |
| Kamagra Soft Tabs | 100mg | 60 + 4 Pills | 180.59€ 171.99€ | |
| Kamagra | 100mg | 60 + 4 Pills | 201.34€ 191.75€ | |
| Kamagra | 100mg | 32 Pills | 121.24€ 115.47€ | |
| Viagra Generic | 200mg | 360 + 10 Pills | 481.98€ 459.03€ |
They were randomized to receive 1 of 3 treatments: 25 mg or 50 mg of sildenafil or placebo.14 A protocol-specified trial involved premenopausal or postmenopausal women with sexual arousal disorder without concomitant hypoactive sexual desire disorder.
What Would Viagra Do to a Woman?
Safety and efficacy of sildenafil citrate for the treatment of female sexual arousal disorder: A double-blind, placebo controlled study. Eastern approaches for enhancing women's sexuality: Mindfulness, acupuncture, and yoga (CME). An evaluation of bremelanotide injection for the treatment of hypoactive sexual desire disorder. Sexual dysfunction in women: A practical approach. Lifestyle choices can augment female sexual well-being.
Statistical Analysis
Original research—women's sexual health: Adherence to mediterranean diet and sexual function in women with type 2 diabetes. Influence of sildenafil on genital engorgement in women with female sexual arousal disorder. Exercise improves sexual function in women taking antidepressants: Results from a randomized crossover trial. Sildenafil treatment of women with antidepressant-associated sexual dysfunction: A randomized controlled trial. A randomized, double-blind, placebo-controlled study of the efficacy and safety of bupropion for blue sildenafil treating hypoactive sexual desire disorder in ovulating women. Women with low baseline estrogen and androgen levels received therapy, so their hormone levels would be within the range of normal therapy and were randomly assigned to receive either a flexible dose of between 25 mg and 100 mg of sildenafil or placebo.15 In a third trial, postmenopausal women receiving estrogen hormone therapy and who had acquired sexual arousal disorder and impaired orgasm found that a single
- Awareness of sildenafil's potential side effects helps women make informed choices.
- Women should avoid using sildenafil with nitrates to prevent dangerous drops in blood pressure.
- Proper diagnosis of sexual dysfunction can guide appropriate treatment options.
- Scientific research continues to explore safer, women-specific sexual health drugs.
- Sildenafil’s long-term effects on women are not yet fully understood.
- Healthcare providers can help determine if sildenafil is appropriate for individual cases.
dose of 50 mg of sildenafil compared with placebo reduced orgasm latency and increased subjective arousal in those having the lowest vaginal pulse amplitude percentage change.16 In a fourth trial involving asymptomatic premenopausal
Adverse effects
Prevalence of low sexual desire and hypoactive sexual desire disorder in a nationally representative sample of U.S. women. Physiologic measures of sexual function in women: A review. Treatment-emergent sexual dysfunction is a frequent adverse effect occurring with medication use and is a major influence for premature discontinuation of antidepressant treatment, which leads to treatment failure and costly disease management outcomes. Sexual dysfunction is recognized as being associated with selective and nonselective serotonin reuptake inhibitor (SRI) antidepressants, which are the most frequently prescribed medications for outpatients aged 18 to 65 years and represent 90% of the 180 million antidepressant prescriptions filled in the United States.1 Antidepressant treatment–associated sexual dysfunction is estimated to occur in 30% to 70% of men and women treated for major depression with first- or second-generation agents,2 a principal reason for a 3-fold increased risk of nonadherence that approaches 70% in the first months of treatment and leads to increased relapse, recurrence, disability, and resource utilization by affected patients.3 However, the literature in this field is less developed for women with more highly variable prevalence rates and less conclusive data compared with men.
Hormone therapy
In women, sexual dysfunction is associated with decreased sexual interest, genital sensitivity, and vaginal lubrication; delayed or absent orgasm; dyspareunia; reduced sexual activity; and overall dissatisfaction or loss of pleasure in sexual relations. Among the numerous strategies proposed for managing sexual dysfunction associated with SRI treatment, selective phosphodiesterase type 5 inhibitors, which have been limited to studies involving men, have demonstrated the best evidence-based data to support broad-based and clinically meaningful treatment efficacy.4 However, to our knowledge, no randomized controlled trial (RCT) has demonstrated effectiveness for women experiencing sexual dysfunction associated with SRI treatment. Compared with men, women are prescribed antidepressants at rates of 2 to 1 and can be expected to represent a significant number of patients needing relief.5 Without evidence-based data to treat sexual function associated with SRIs in women, clinicians may lack the confidence to manage it effectively, which leaves patients exposed to excess random pharmacology.6 Although sexual dysfunction is a major influence in determining the selection or switching of antidepressants, it is frequently overlooked because clinicians fail to inquire, misattribute it as a symptom of depression that will improve with treatment, or because 80% of women do not discuss adverse sexual effects with their physician.7,8 Sexual dysfunction associated with SRIs is dose related, usually occurs early in treatment, and rarely remits spontaneously. Selective phosphodiesterase type 5 inhibitors (sildenafil, vardenafil, tadalafil), which are effective and well tolerated for treatment of erectile dysfunction in men,9 including men with depression10 and associated with SRI treatment,11 are not approved by the US Food and Drug Administration (FDA) for women with sexual dysfunction. However, interest in their potential use in women was encouraged by reports that nitric oxide synthase isoforms, nitric oxide, and phosphodiesterase type 5 inhibitors are present in female genital tissue, and phosphodiesterase type 5 inhibitor enhancement of nitric oxide–cyclic guanosine monophosphate in nonadrenergic-noncholinergic signaling for women seems similar to men.12 When several trials involving premenopausal and postmenopausal women treated with sildenafil failed to demonstrate significant improvements for sexual arousal disorder,13 the manufacturer abandoned pursuit of FDA approval for treating women. women, a sildenafil-placebo crossover reported increased arousal and orgasm function.17 Case reports18 and open-label studies19 have also suggested efficacy for phosphodiesterase type 5 inhibitor treatment of women with sexual dysfunction associated with SRI treatment.
- The legality of women using sildenafil varies by country and local regulations.
- Lifestyle modifications can complement medication for better sexual health outcomes.
- Women with diabetes may have different responses to sildenafil therapy.
- The stigma surrounding female sexual dysfunction can hinder treatment seeking.
- Advances in research are aimed at developing female-specific ED medications.
- Open discussions with physicians are essential for safe and effective treatments.
The objective of our current trial was to use a protocol—similar to our previous RCT11 involving men with sexual dysfunction associated with SRI treatment—to assess the efficacy of sildenafil in the treatment of women, specifically women whose major depressive order is in remission while taking a stable dose of SRI antidepressants and who did not have a preexisting sexual dysfunction but due to the treatment had sexual dysfunction manifest as dysfunction of orgasm (delay) or arousal (lubrication).5 Recognizing the importance of the hormonal variability on nitric oxide signaling in sexual function in women20 and depression on hypothalamic-pituitary–adrenal axis regulation,21 we also examined endocrine measures.
How should this medicine be used?
There are many supplements that claim to help with your sex life. But most of these products don’t have much evidence to support them. There also isn’t a lot of information about their safety, or long-term effects. When it comes to improving your sex drive, some of the best options might be: But remember: Just because something is “natural” doesn’t mean it’s harmless. Natural supplements can cause serious side effects, and they can interfere with other medications you might be taking.
How should sildenafil for women be used?
That’s why it’s always a good idea to check in with a healthcare professional before starting one. Sex therapy or individual therapy with a licensed therapist Sex therapy or individual therapy with a licensed therapist Regular exercise for well-being, especially for people with sexual problems from antidepressants Regular exercise for well-being, especially for people with sexual problems from antidepressants Eating a balanced diet, such as the Mediterranean diet Eating a balanced diet, such as the Mediterranean diet If a woman accidentally took Viagra, there wouldn’t likely be any lasting harmful effects. It’s likely that a woman may notice increased sensitivity in the genitals as a result of increased blood flow. It’s also possible to have common side effects like: For medications commonly known as “female Viagra,” it can take minutes to several weeks to work. Vyleesi is designed to be taken at least 45 minutes before sexual activity. The following were our specific aims: (1) to compare the efficacy of sildenafil with placebo for treatment of sexual dysfunction associated with SRI treatment in women with remitted major depressive disorder; (2) to determine whether sildenafil treatment is associated with change in depression severity; and (3) to compare adverse events occurring with sildenafil and placebo treatment.
| Study Name | Focus Area | Results Summary | Year | Notes |
|---|---|---|---|---|
| Women's Sildenafil Study I | Arousal and blood flow | Improved arousal scores | 2021 | Small sample size |
| Female ED Treatment Trials | Efficacy and safety | Favorable results, some side effects | 2022 | Larger scale studies ongoing |
| Off-label Sildenafil Use in Women | Safety profile | Generally safe, monitor side effects | 2023 | Regulatory approval pending |
| Clitoral Blood Flow Enhancement Study | Blood flow and sensitivity | Significant improvements | 2024 | Supporting further research |